Detalhe da pesquisa
1.
Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia.
Ann Hematol
; 98(5): 1217-1224, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30824956
2.
A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim.
J Cancer Res Clin Oncol
; 144(6): 1087-1095, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29671069